Eternity Healthcare and PharmaNova Sign Letter of Intent to Develop New Branded Pharmaceuticals
7/15/2013 9:21:28 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
VANCOUVER, British Columbia and VICTOR, N.Y., July 15, 2013 (GLOBE NEWSWIRE) -- Eternity Healthcare, Inc. (OTC:ETAH), or 'Eternity', a medical device company, announced today that it has signed a letter of Intent with PharmaNova Inc. of New York to develop a new generation of steroids and steroids related pharmaceuticals for rapid subcutaneous absorption. The companies will utilize PharmaNova's NovaSperseSM nanoparticle technology to enhance the aqueous dissolution of lipid soluble drugs enabling them to be administered using Eternity Healthcare's – Comfort-In™ needle-free injection system.
Help employers find you! Check out all the jobs and post your resume.
comments powered by